The IVDR certification is a critical regulatory approval that allows medical devices and software to be marketed within the European Union. For Qiagen, receiving this certification for its Clinical Insight Interpret software not only validates the software's quality and compliance with EU standards but also significantly enhances its marketability and potential adoption by healthcare providers in the EU. This development is likely to be viewed positively by investors, as it opens up new revenue opportunities for Qiagen in a major market.